312 related articles for article (PubMed ID: 26371699)
1. Systemic therapy for pulmonary carcinoids.
Marquez-Medina D; Popat S
Lung Cancer; 2015 Nov; 90(2):139-47. PubMed ID: 26371699
[TBL] [Abstract][Full Text] [Related]
2. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
Gálffy G
Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of typical and atypical lung carcinoids.
Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
[TBL] [Abstract][Full Text] [Related]
5. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
Swarts DR; Ramaekers FC; Speel EJ
Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
[TBL] [Abstract][Full Text] [Related]
7. Carcinomas of the lung with neuroendocrine differentiation.
Carter D; Yesner R
Semin Diagn Pathol; 1985 Nov; 2(4):235-54. PubMed ID: 3039628
[TBL] [Abstract][Full Text] [Related]
8. Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine.
Travis WD
Thorac Surg Clin; 2014 Aug; 24(3):257-66. PubMed ID: 25065926
[TBL] [Abstract][Full Text] [Related]
9. The molecular pathogenesis and management of bronchial carcinoids.
Cakir M; Grossman A
Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
[TBL] [Abstract][Full Text] [Related]
10. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary carcinoid and related tumours.
Hasleton PS; Bostanci G
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
[TBL] [Abstract][Full Text] [Related]
12. Sustentacular cells in pulmonary neuroendocrine tumours.
Gosney JR; Denley H; Resl M
Histopathology; 1999 Mar; 34(3):211-5. PubMed ID: 10217561
[TBL] [Abstract][Full Text] [Related]
13. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
[TBL] [Abstract][Full Text] [Related]
15. Bronchopulmonary neuroendocrine tumors.
Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
[TBL] [Abstract][Full Text] [Related]
16. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pulmonary neuroendocrine tumours: state of the art and future developments.
Gridelli C; Rossi A; Airoma G; Bianco R; Costanzo R; Daniele B; Chiara GD; Grimaldi G; Irtelli L; Maione P; Morabito A; Piantedosi FV; Riccardi F
Cancer Treat Rev; 2013 Aug; 39(5):466-72. PubMed ID: 22818212
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in the Management of Typical and Atypical Lung Carcinoids.
Prinzi N; Rossi RE; Proto C; Leuzzi G; Raimondi A; Torchio M; Milione M; Corti F; Colombo E; Prisciandaro M; Cascella T; Spreafico C; Beninato T; Coppa J; Lo Russo G; Di Bartolomeo M; de Braud F; Pusceddu S
Clin Lung Cancer; 2021 May; 22(3):161-169. PubMed ID: 33618994
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
